Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Radiometer’s AQT90 FLEX Drives Kettering’s Gold Standard Cardiac Treatment Pathway

Published: Tuesday, February 19, 2013
Last Updated: Monday, February 18, 2013
Bookmark and Share
POC testing with AQT90 FLEX allows triple test on admission and again 90 minutes later.

The Chest Pain Assessment Unit at Kettering General Hospital (KGH) relies on Radiometer’s compact AQT90 FLEX point-of-care (POC) analyzer to provide a gold standard, streamlined treatment pathway for patients presenting with cardiac sounding chest pain.

Sarah Mounsey, a cardiac outreach nurse at KGH, explained: “Chest pain patients arriving at KGH are assessed by a cardiac outreach nurse and, if they fit certain criteria, will be accepted onto the triple test pathway. We assess the type of chest pain the patient has and how long they have been suffering from it, look at the ECG and consider any other risk factors that may exist, before deciding whether triple cardiac marker testing is appropriate.”

Faye Robson, also a cardiac outreach nurse at KGH, continued: “Historically, patients have been admitted to hospital and then had to wait 10 hours before having a troponin test to eliminate cardiac problems, and allow them to be discharged. POC testing with the AQT90 FLEX allows us to perform the triple test on admission and again 90 minutes later, which means much less time is spent waiting for test results. We can turn patients around more quickly - those with negative results go home much sooner - and make more efficient use of our resources. It is a very, very positive experience for both the patient and the hospital.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Radiometer Acquires HemoCue
The acquisition brings together two companies with similar core values, providing high quality products for acute care and point-of-care testing worldwide.
Tuesday, June 10, 2014
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos